Biblio
Export 1296 results:
Author Title Type [ Year
Filters: First Letter Of Last Name is A [Clear All Filters]
“Associations of the Harvard Automated Phone Task and Alzheimer's Disease Pathology in Cognitively Normal Older Adults: Preliminary Findings.”, J Alzheimers Dis, vol. 94, no. 1, pp. 217-226, 2023.
, “Best Medicine for Dementia: The Life-Long Defense of the Brain.”, J Alzheimers Dis, vol. 94, no. 1, pp. 51-66, 2023.
, “Can Traditional Board Games Prevent or Slow Down Cognitive Impairment? A Systematic Review and Meta-Analysis.”, J Alzheimers Dis, vol. 95, no. 3, pp. 829-845, 2023.
, “Cerebral Gray and White Matter Monogalactosyl Diglyceride Levels Rise with the Progression of Alzheimer's Disease.”, J Alzheimers Dis, vol. 95, no. 4, pp. 1623-1634, 2023.
, “Cerebrospinal Fluid sTREM-2, GFAP, and β-S100 in Symptomatic Sporadic Alzheimer's Disease: Microglial, Astrocytic, and APOE Contributions Along the Alzheimer's Disease Continuum.”, J Alzheimers Dis, vol. 92, no. 4, pp. 1385-1397, 2023.
, “Cleveland Clinic Cognitive Battery (C3B): Normative, Reliability, and Validation Studies of a Self-Administered Computerized Tool for Screening Cognitive Dysfunction in Primary Care.”, J Alzheimers Dis, vol. 92, no. 3, pp. 1051-1066, 2023.
, “Cleveland Clinic Cognitive Battery (C3B): Normative, Reliability, and Validation Studies of a Self-Administered Computerized Tool for Screening Cognitive Dysfunction in Primary Care.”, J Alzheimers Dis, vol. 92, no. 3, pp. 1051-1066, 2023.
, “Coexistence of Amyotrophic Lateral Sclerosis and Alzheimer's Disease: Case Report and Review of the Literature.”, J Alzheimers Dis, vol. 95, no. 4, pp. 1383-1399, 2023.
, “Coexistence of Amyotrophic Lateral Sclerosis and Alzheimer's Disease: Case Report and Review of the Literature.”, J Alzheimers Dis, vol. 95, no. 4, pp. 1383-1399, 2023.
, “Computational Evaluation of Azadirachta indica-Derived Bioactive Compounds as Potential Inhibitors of NLRP3 in the Treatment of Alzheimer's Disease.”, J Alzheimers Dis, vol. 94, no. s1, pp. S67-S85, 2023.
, “Computational Evaluation of Azadirachta indica-Derived Bioactive Compounds as Potential Inhibitors of NLRP3 in the Treatment of Alzheimer's Disease.”, J Alzheimers Dis, vol. 94, no. s1, pp. S67-S85, 2023.
, “Computational Evaluation of Azadirachta indica-Derived Bioactive Compounds as Potential Inhibitors of NLRP3 in the Treatment of Alzheimer's Disease.”, J Alzheimers Dis, vol. 94, no. s1, pp. S67-S85, 2023.
, “Costs of Dementia in Low- And Middle-Income Countries: A Systematic Review.”, J Alzheimers Dis, vol. 91, no. 1, pp. 115-128, 2023.
, “Is Dementia Associated with COVID-19 Mortality? A Multicenter Retrospective Cohort Study Conducted in 50 Hospitals in Germany.”, J Alzheimers Dis, vol. 91, no. 2, pp. 719-726, 2023.
, “Detecting Anosognosia from the Prodromal Stage of Alzheimer's Disease.”, J Alzheimers Dis, vol. 95, no. 4, pp. 1723-1733, 2023.
, “Diagnostic Performance of Cerebrospinal Fluid Neurofilament Light Chain and Soluble Amyloid-β Protein Precursor β in the Subcortical Small Vessel Type of Dementia.”, J Alzheimers Dis, vol. 96, no. 4, pp. 1515-1528, 2023.
, “Different Trajectories of Apathy and Depression Among Subjective Cognitive Impairment Individuals with or without Conversion to Dementia: Results from the Memento Cohort in France.”, J Alzheimers Dis, vol. 95, no. 2, pp. 415-426, 2023.
, “Disrupted excitation-inhibition balance in cognitively normal individuals at risk of Alzheimer's disease.”, bioRxiv, 2023.
, “Early Amnestic Mild Cognitive Impairment Is Associated with Reduced Total Cerebral Blood Flow with no Brain Tissue Loss.”, J Alzheimers Dis, vol. 91, no. 4, pp. 1313-1322, 2023.
, “Early Depressive Symptoms Predict Faster Dementia Progression in Autosomal-Dominant AD”, J Alzheimers Dis, vol. 92, no. 3, pp. 911-923, 2023.
, “Early Depressive Symptoms Predict Faster Dementia Progression in Autosomal-Dominant AD”, J Alzheimers Dis, vol. 92, no. 3, pp. 911-923, 2023.
, “Early Diagnosis of Mild Cognitive Impairment due to Alzheimer's Disease Using a Composite of MemTrax and Blood Biomarkers.”, J Alzheimers Dis, vol. 94, no. 3, pp. 1093-1103, 2023.
, “Early Diagnosis of Mild Cognitive Impairment due to Alzheimer's Disease Using a Composite of MemTrax and Blood Biomarkers.”, J Alzheimers Dis, vol. 94, no. 3, pp. 1093-1103, 2023.
, “Evaluation of Blood-Based Plasma Biomarkers as Potential Markers of Amyloid Burden in Preclinical Alzheimer's Disease.”, J Alzheimers Dis, vol. 92, no. 1, pp. 95-107, 2023.
, “Evaluation of Blood-Based Plasma Biomarkers as Potential Markers of Amyloid Burden in Preclinical Alzheimer's Disease.”, J Alzheimers Dis, vol. 92, no. 1, pp. 95-107, 2023.
,